C-101 | Comparison of Direct Oral Anticoagulants versus Warfarin in Patients with Heart Failure with Reduced Ejection Fraction: A Clinical Outcomes Analysis
Optimal anticoagulation strategy for patients with heart failure with reduced ejection fraction (HFrEF) requiring left ventricular assist devices (LVADs) remains controversial. While warfarin has been the standard of care, direct oral anticoagulants (DOACs) are increasingly being used despite limited evidence.
Authors
- Mohammed Najdat Seijari (ORCID: https://orcid.org/0000-0002-4778-1831)
- Flora Ajayi (ORCID: https://orcid.org/0009-0007-6190-2277)
- Yash Patel (ORCID: https://orcid.org/0009-0002-9807-4819)
- Godbless Ajenaghughrure
- Kayode Emmanuel Ogunniyi (ORCID: https://orcid.org/0009-0002-4004-9290)
- Taraneh Zamani (ORCID: https://orcid.org/0009-0007-8281-0363)
- Karldon Nwaezeapu
- God-dowell O. Odukudu
- Ekow Essien
- Pranita Rajbhandari
- Divine Dele
Institutions
- Aurora Health Care (US)
- Newark Beth Israel Medical Center (US)
- Trinity Health (US)
- Union University (US)
- Union Institute & University (US)
- Richmond University Medical Center (US)
- Good Samaritan Hospital (US)
- Morehouse School of Medicine (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.jscai.2025.103091
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00